scholarly journals Influence of Intranasal Drugs on Human Nasal Mucociliary Clearance and Ciliary Beat Frequency

2019 ◽  
Vol 11 (3) ◽  
pp. 306 ◽  
Author(s):  
Jian Jiao ◽  
Luo Zhang
Thorax ◽  
1985 ◽  
Vol 40 (8) ◽  
pp. 607-612 ◽  
Author(s):  
P J Stanley ◽  
W M Griffin ◽  
R Wilson ◽  
M A Greenstone ◽  
I S Mackay ◽  
...  

Thorax ◽  
1986 ◽  
Vol 41 (7) ◽  
pp. 519-523 ◽  
Author(s):  
P J Stanley ◽  
R Wilson ◽  
M A Greenstone ◽  
L MacWilliam ◽  
P J Cole

2012 ◽  
Vol 29 (4) ◽  
pp. 350-358 ◽  
Author(s):  
Frank Begrow ◽  
Corinna Böckenholt ◽  
Martina Ehmen ◽  
Thomas Wittig ◽  
Eugen J. Verspohl

CHEST Journal ◽  
1987 ◽  
Vol 92 (3) ◽  
pp. 491-493 ◽  
Author(s):  
Ido Katz ◽  
Tzila Zwas ◽  
Gerald L. Baum ◽  
Ephraim Aharonson ◽  
Benjamin Belfer

1995 ◽  
Vol 109 (1) ◽  
pp. 24-26 ◽  
Author(s):  
G. K. Scadding ◽  
V. J. Lund ◽  
Y. C. Darby

AbstractThe mucociliary escalator is the first line of defence of the upper and lower respiratory tracts (Greenstone and Cole, 1985; Sleighet al., 1988). Failure of mucociliary clearance is associated with chronic or recurrent respiratory tract infection. Ten patients with chronic rhinosinusitis underwent nasal brushings for the assessment of ciliary beat frequency. In two no beating cilia were seen; in the remainder the mean value was 9.3 Hz ± 2.3; range 6.1–12.8 Hz (n = 8).Following three months continuous oral antibiotic therapy repeat nasal brushings demonstrated increased ciliary beat frequencies in all patients, mean value 13.7 Hz ± 1.6; range 11.5–16.3 Hz (n = 10); (p<0.001 pairedt-test).Depression of mucociliary clearance can occur secondarily to chronic infection and is improved by prolonged antibiotics.


2014 ◽  
Vol 306 (6) ◽  
pp. L584-L589 ◽  
Author(s):  
K. L. Bailey ◽  
S. J. Bonasera ◽  
M. Wilderdyke ◽  
B. W. Hanisch ◽  
J. A. Pavlik ◽  
...  

The elderly are at much higher risk for developing pneumonia than younger individuals. Pneumonia is a leading cause of death and is the third most common reason for hospitalization in the elderly. One reason that elderly people may be more susceptible to pneumonia is a breakdown in the lung's first line of defense, mucociliary clearance. Cilia beat in a coordinated manner to propel out invading microorganisms and particles. Ciliary beat frequency (CBF) is known to slow with aging, however, little is known about the mechanism(s) involved. We compared the CBF in BALB/c and C57BL/6 mice aged 2, 12, and 24 mo and found that CBF diminishes with age. Cilia in the mice at age 12 and 24 mo retained their ability to be stimulated by the β2 agonist procaterol. To help determine the mechanism of ciliary slowing, we measured protein kinase C alpha and epsilon (PKCα and PKCε) activity. There were no activity differences in PKCα between the mice aged 2, 12, or 24 mo. However, we demonstrated a significantly higher PKCε activity in the mice at 12 and 24 mo than the in the mice 2 mo of age. The increase in activity is likely due to a nearly threefold increase in PKCε protein in the lung during aging. To strengthen the connection between activation of PKCε and ciliary slowing, we treated tracheas of mice at 2 mo with the PKCε agonist 8-[2-(2-pentylcyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA). We noted a similar decrease in baseline CBF, and the cilia remained sensitive to stimulation with β2 agonists. The mechanisms for the slowing of baseline CBF have not been previously determined. In this mouse model of aging we were able to show that decreases in CBF are related to an increase in PKCε activity.


2020 ◽  
Vol 7 (1) ◽  
pp. e000574
Author(s):  
Cedar Fowler ◽  
Un-In Wu ◽  
Robyn Shaffer ◽  
Caroline Smith ◽  
Lisa Barnhart ◽  
...  

RationalePulmonary non-tuberculous mycobacterial (PNTM) disease has increased over the past several decades, especially in older women. Abnormal mucociliary clearance and abnormal nasal nitric oxide (nNO) have been associated with PNTM disease in other patient cohorts. Mucociliary clearance can be affected by NO-cyclic guanosine monophosphate signalling and, therefore, modulation of the pathway may be possible with phosphodiesterase inhibitors such as sildenafil as a novel therapeutic approach.ObjectiveTo define ex vivo characteristics of PNTM disease affected by sildenafil.MethodsSubjects with PNTM infections were recruited into an open-label dose-escalation trial of sildenafil. Laboratory measurements and mucociliary measurements—ciliary beat frequency, nNO and 24-hour sputum production—were collected throughout the study period. Patients received sildenafil daily during the study period, with escalation from 20 to 40 mg three times per day.Measurements and main resultsIncreased ciliary beat frequency occurred after a single dose of 40 mg sildenafil and after extended dosing of 40 mg sildenafil. The increase ciliary beat frequency was not seen with 20 mg sildenafil dosing. There were no changes in sputum production, nNO production, Quality of Life-Bronchiectasis-NTM module (QOL-B-NTM) questionnaire or the St George’s Respiratory Questionnaire during the study period.ConclusionSildenafil, 40 mg, increased ciliary beat frequency acutely as well as with extended administration.


Sign in / Sign up

Export Citation Format

Share Document